Joseph Chao, MD from the City of Hope speaks about the Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite…
Browsing: Gastrointestinal
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Establishment of Patient-derived Succinate…
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Establishment of Patient-derived Succinate…
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Location of Gastrointestinal Stromal…
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Location of Gastrointestinal Stromal…
Ajay Goel, Ph.D., AGAF, chair of City of Hope’s Department of Molecular Diagnostics and Experimental Therapeutics speaks about Assessment of…
Ajay Goel, Ph.D., AGAF, chair of City of Hope’s Department of Molecular Diagnostics and Experimental Therapeutics speaks about Assessment of…
Joseph Chao, MD from the City of Hope speaks about the Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite…
David Illson, MD, Ph.D., Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College speaks…
Ajay Goel, Ph.D., AGAF, chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope speaks about…
Yelena Y. Janjigian, MD from Memorial Sloan Kettering Cancer Center speaks about ASCO 2021 Abstract FDA Approves Merck’s KEYTRUDA® (pembrolizumab)…
David Ilson, MD from the Memorial Sloan Kettering Cancer Center speaks about the Top 5 ASCO 2021 Abstracts in Gastrointestinal…
Timothy Ritter, MD, Senior Medical Director, Department of Research and Education GI Alliance Research speaks about U.S. FDA Grants De…
Linghua Wang, MD, PhD of MD Anderson speaks about Single-cell Analysis Of Metastatic Gastric Cancer Finds Diverse Tumor Cell Populations…
Manish A. Shah, MD from Weill Cornell Medicine and New York-Presbyterian discuss the ASCO Pubs – Phase III Study to…
Sheela Rao, MDS Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust discusses Incyte Announces Acceptance and Priority Review of…
Josep Tabernero, MD, PhD, Head of Medical Oncology at Vall d’Hebron Barcelona Hospital, and Director, Vall d’Hebron Institute of Oncology…
Sophie G Kellaway and Prof Constanze Bonifer from the Institute of Cancer and Genomic Sciences, University of Birmingham speaks about…
Kohei Shitara, MD, Chief, Department of Gastrointestinal Oncology of the National Cancer Center Hospital East, Kashiwa discusses The impact of…
Michele Ghidini, MD, Ph.D., Medical Oncologist, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan, Italy speaks about Body weight loss…
Prof. Dan Aderka of the Sheba Medical Center discusses the Optimal Sequence of Targeted Agents for All RAS & BRAF…
Shahid Gilani, MD from University Hospital Of North Midlands speaks about the Impact of haemoglobin level and blood transfusion on…
Visit https://BeaconMedIC.com for more media and information.Subscribe to audio podcast at http://BTJBeacon.libsyn.com/rss/audioDrs. Charu Aggarwal and Jack West host Dr. Mark…
Shailja Shah, MD, MPH. at Vanderbilt Ingram Cancer Center discusses a Study which gauges specific site gastric cancer risks among…
Ari Rosenberg, MD at The University of Chicago discusses an abstract from ASCO 2020 entitled Dose and volume de-escalation for…
Benoit You, MD, Ph.D. from Centre Hospitalier Lyon-Sud discusses an ASCO 2020 abstract entitled ROPHIMMUN phase II trial, cohort A…
Johanna C. Bendell, MD from Sarah Cannon discusses and ASCO 2020 abstract entitled A phase I/II, two-part, multicenter, first-in-human study…
Ajay Goel, Ph.D. of the City of Hope speaks about the AACR 2020 Abstract 1084: EpiPanGI-Dx: A cell-free DNA methylation…
Charles S. Fuchs, MD, MPH at Yale Cancer discusses how Checkpoint Inhibitors are a “real player” in Gastric Cancers. Bottom…
Charles S. Fuchs, MD, MPH at Yale Cancer discusses the Current Role for Pembrolizumab in Gastric Cancer using the latest…
Charles S. Fuchs, MD, MPH at Yale Cancer gives an overview of a study presented at ASCO 2020 entitled Pembrolizumab…
In this edition of The Onco’Zine Brief, Peter Hofland, Ph.D., talks with Vince McRuiz and Margo Shoup, MD, FACS.Margo Shoup…
Margaret von Mehren, MD of Fox Chase Cancer Center @FoxChaseCancer discusses the FDA Full Approval of Deciphera Pharmaceuticals’ QINLOCK for…
Margaret von Mehren, MD of Fox Chase Cancer Center @FoxChaseCancer discusses the FDA Full Approval of Deciphera Pharmaceuticals’ QINLOCK for…
Margaret von Mehren, MD of Fox Chase Cancer Center @FoxChaseCancer discusses the FDA Full Approval of Deciphera Pharmaceuticals’ QINLOCK for…
Zev A. Wainberg, MD Associate Professor Of Medicine Co-Director GI Oncology Program David Geffen School of Medicine at UCLA gives…
Experience with COVID-19 in Wuhan, China shows up to half of patients present with a digestive symptom as chief complaint…
– Data from pivotal study demonstrate safety and efficacy regardless of prior gastrectomy in previously treated patients with metastatic gastric…
Earn CME: https://naccme.com/program/19-gdugi-2 In this webcast from the ‘Making Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic…
Bradley E. Bernstein, MD @BradEBernstein @willflavahan of @MassGeneralNews answers how this affects clinicians on the cause of drug resistance found…
Most cases of gastrointestinal stromal tumor (GIST), a form of soft tissue cancer (sarcoma), are caused by gene mutations that…
Bradley E. Bernstein, MD @BradEBernstein @willflavahan of @MassGeneralNews answers commonly asked questions on the cause of drug resistance found in a form…
Bradley E. Bernstein, MD @BradEBernstein @willflavahan of @MassGeneralNews explains the cause of drug resistance found in a form of intestinal tumor. ___________…
Thomas A. Abrams Senior Physician and Assistant Professor of Medicine at Harvard Medical School tells us his thoughts on KEYNOTE-62.…
Lowell Anthony MD Of Markey Cancer Center Discusses When Do You Prescribe Bland Vs Chemo Or Radio Embolization: Chemo Embolization…
Lowell Anthony MD Of Markey Cancer Center Discusses Inducing Embolization Syndrome When Performing infarction: Not Uncommon To Take 4-8 Weeks…
Lowell Anthony MD Of Markey Cancer Center Discusses Evaluating mTOR Inhibitor Everolimus With Embolotherapy: Objective Response Rate Of 57 We…
Yousuf Zafar, MD, discusses the importance of patient care. Financial barriers to clinical trial enrollment are an area of active…
Yousuf Zafar, MD, discusses the importance of questioning the qaulity and completenesss of Data. Financial barriers to clinical trial enrollment…
Yousuf Zafar, MD, discuses the role of Real World Evidence in cancer care. Financial barriers to clinical trial enrollment are…